Eam Investors, LLC Astria Therapeutics, Inc. Transaction History

Eam Investors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jul 12, 2023	SELL	$11.2 - $15.79 $2.4 Million - $3.38 Million	-214,326 Reduced 74.82%	72,129 $959,000
Q1 2023 May 12, 2023	BUY	$11.2 - $15.79 $2.19 Million - $3.08 Million	195,110 Added 213.6%	286,455 $3.81 Million
Q4 2022 Feb 14, 2023	BUY	$7.44 - $14.89 $679,606 - $1.36 Million	91,345 New	91,345 $1.36 Million

110

48.6M

48K

9.3K

Ticker ATXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,178,000
Market Cap $112M
Description
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.